Fundraising Fox
Mårten Steen
InvestorManaging Partner | MD PhD at HealthCap · Senior Partner at EV Private Equity · Board director at Mahzi Therapeutics · Board director at Cortendo · Director at BioClin Therapeutics
Stockholm
Writes $100K – $5M checks · typically $1.5M
Find your path to Mårten
61 people in our graph share verified history with Mårten — schools, employers, funds. One of them is your warm intro.
Shantanu AgarwalunlockedMårten: together at EV Private Equity (2015–2018)
×5Mårten: together at EV Private Equity
Mårten: together at Mahzi Therapeutics
×4Mårten: together at BioClin Therapeutics
About
Managing partner who rejoined HealthCap in 2010. Previously led global business development at Merck Serono. A medical doctor trained at Lund University with a PhD in clinical chemistry and a BSc in business administration.
Contact· self-published, not guessed
Board director at Mahzi Therapeutics
Intro paths
→
In turn, Mårten can intro founders to Mahzi Therapeutics's investors below.
Mahzi Therapeutics's investors · 7
Co-founders at Mahzi Therapeutics
YW
Yael WeissExecutive Officer, Director
Board director at Cortendo
Intro paths
→
In turn, Mårten can intro founders to Cortendo's investors below.
Cortendo's investors · 1
Director at BioClin Therapeutics
Intro paths
→
In turn, Mårten can intro founders to BioClin Therapeutics's investors below.
Experience
- AMRA MedicalBoard Membercurrent2026 — presentSweden
- NeobiomicsBoaed Membercurrent2026 — presentSweden
- Kivu BioscienceMember of the Management Boardcurrent2024 — present
- Mahzi TherapeuticsBoard Membercurrent2020 — present
- PriotheraBoard Membercurrent2020 — presentDublin, County Dublin, Ireland
- HealthCapManaging Partnercurrent2010 — present
- Vivet TherapeuticsBoard Membercurrent2018 — presentGreater Paris Metropolitan Region
- PrecirixBoard Membercurrent2018 — presentBrussels Metropolitan Area
- Hemab TherapeuticsBoard Member2021 — 2026Copenhagen, Capital Region of Denmark, Denmark
- Aro BiotherapeuticsBoard Member2021 — 2024Philadelphia, Pennsylvania, United States
- AdcendoBoard Member2021 — 2022Copenhagen, Capital Region of Denmark, Denmark
- Strongbridge Biopharma plcBoard Member2014 — 2021Greater Dublin
- Rainier Therapeutics (Previously BioClin Tx)Board Member2014 — 2020San Francisco Bay Area
- Wilson TherapeuticsBoard Member2012 — 2017Greater Stockholm Metropolitan Area
- Altimmune, Inc.Board Member2015 — 2016London Area, United Kingdom
- Ultragenyx Pharmaceutical Inc.Board Member2011 — 2014San Francisco Bay Area
- FerroKin BioSciencesBoard Member2010 — 2012San Francisco Bay Area
- Merck SeronoDirector Licensing2008 — 2010
- HealthCapMedical Associate2005 — 2008
- Lund University/Novo NordiskResearcher1999 — 2005
Skills & more
Pharmaceutical Industry2Life Sciences1BiotechnologyStrategyVenture Capital1
From Mårten's professional profile.
Investments
Investor
AdcendoAMRA Medical ABFerroKin BiosciencesImmune Targeting SystemsNeobiomicsPrecirixPriothera Ltd.Ultragenyx PharmaceuticalWilson Therapeutics
Per curated public sources.
Colleagues at HealthCap
Alex Valcu
Partner at HealthCap
Anki Forsberg
Partner and Chairman at HealthCap
Björn Odlander
Managing Partner at HealthCap
Carl Kilander
Partner at HealthCap
Carl-Johan Dalsgaard
Venture Partner | MD PhD at HealthCap
Dag Richter
General Partner at HealthCap
Daniel Karsberg
Partner | MSc at HealthCap
Daniel Schafer
General Partner at HealthCap
Frequently asked questions
- Who is Mårten Steen?
- Managing partner who rejoined HealthCap in 2010. Previously led global business development at Merck Serono. A medical doctor trained at Lund University with a PhD in clinical chemistry and a BSc in business administration.
- Where does Mårten Steen work?
- Mårten Steen is Managing Partner | MD PhD at HealthCap and Board director at Mahzi Therapeutics and Board director at Cortendo.
- What check size does Mårten Steen write?
- Mårten Steen typically writes checks of $100K – $5M.
- What companies has Mårten Steen invested in?
- Investments tracked here include Adcendo, AMRA Medical AB, FerroKin Biosciences, Immune Targeting Systems, Neobiomics, Precirix, Priothera Ltd., Ultragenyx Pharmaceutical, Wilson Therapeutics.
- Where did Mårten Steen go to school?
- Mårten Steen studied at Lund University (Doctor of Medicine - MD); Lund University (Doctor of Philosophy - PhD, Medicine); Lund University School of Economics and Management (Bachelor of Business Administration - BBA).
Same school
Also attended Lund University163
Alexander Fred-OjalaInvestor at EQT VenturesGustav von SydowInvestor at EQT VenturesRony Patishi-ChillimInvestor at Israel Cleantech VenturesJakob PalmstiernaPresident at GSRMargot HuysmansAnalyst at Heran PartnersAnna HauptInvestor at Industrifonden
+ 157 more
Also attended Lund University School of Economics and Management48
Alexander Fred-OjalaInvestor at EQT VenturesVilton BastiampillaiAssociate – Equity Capital Markets at ScietyJohan ÅkessonInvestment Associate at NordicNinjaClara NorgrenInvestor at IndustrifondenManfred von RichthofenInvestor at Almi InvestLoh Jia YiManager at SGInnovate
+ 42 more
